Who are Vitamin B1-ratiopharm's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Vitamin B1.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vitamin-b1-ratiopharm.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Vitamin B1-ratiopharm — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin B1-ratiopharm (Vitamin B1-ratiopharm) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B1 supplement. Area: Nutritional deficiency / Neurology.

marketed Vitamin B1 supplement Thiamine pyrophosphate-dependent enzymes Nutritional deficiency / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Vitamin B1-ratiopharm (Vitamin B1-ratiopharm) — Medical University of Vienna. Vitamin B1 (thiamine) acts as a coenzyme in carbohydrate metabolism and nervous system function.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Vitamin B1-ratiopharm TARGET	Vitamin B1-ratiopharm	Medical University of Vienna	marketed	Vitamin B1 supplement	Thiamine pyrophosphate-dependent enzymes
Vitamin B1	Vitamin B1	Shanghai Zhongshan Hospital	marketed	Vitamin B complex	Thiamine pyrophosphate-dependent enzymes

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B1 supplement class)

Medical University of Vienna · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vitamin B1-ratiopharm — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-b1-ratiopharm. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab